Environmental Persistence of Pharmaceuticals (Pseudo-persistence): A Sustainability Perspective
A focused scientific collaboration between PharmHive and AFÖP combining an academic article, social media post, and joint webinar to explain pharmaceutical pseudo-persistence and its environmental implications.
Project Overview
This project explains the concept of pseudo-persistence — the continuous introduction of pharmaceuticals into the environment despite their low individual persistence — in a clear and accessible way. The collaboration pairs PharmHive's content and coordination with AFÖP's participant outreach and expert speaker identification, resulting in a peer-level scientific article, a summarizing social media carousel, and a joint webinar up to 3 hours.
Lead Committee
Sustainable Pharma Committee
Partner Organization
AFÖP (Austria)
PharmHive Project Lead
Ece Bıyıkçı
Sustainable Pharma Committee Director
AFÖP Project Director
Bao Chau Dao
AFÖP (Austria)
Deadline
June 20, 2026
Project Objectives
- Explain the concept of pseudo-persistence in a clear and accessible way
- Highlight the environmental and sustainability implications of pharmaceutical persistence
- Translate scientific knowledge into public-facing content
Deliverables
Short Article (3–4 pages, PDF)
Review-style article covering pseudo-persistence, environmental pathways, ecosystem implications, and sustainability & policy perspectives from EU and Türkiye
Carousel Post (Instagram/LinkedIn)
Summary of article key concepts with sustainability and EU perspectives, directing audience to the full article
Joint Webinar (up to 3 hours)
1 hour expert presentation + 1 hour expert presentation + 30 min open discussion + 30 min organizational matters, featuring a qualified guest speaker